Your browser doesn't support javascript.
loading
Growth promoting effect of short-term gonadotropin releasing hormone agonist with or without growth hormone in girls with early puberty / 소아과
Korean Journal of Pediatrics ; : 198-204, 2007.
Article in Korean | WPRIM | ID: wpr-71847
ABSTRACT

PURPOSE:

The hope that arresting pubertal developement might increase final adult height has led to an attempt to use GnRH agonist (GnRHa) in children with early puberty and poor growth prognosis. We investigated the growth-promoting effect of GnRH agonists with or without growth hormone (GH) in girls with early puberty and decreased predicted adult height (PAH).

METHODS:

Thirty five girls with advanced bone age and early pubertal signs were randomized for treatment for about 1 year with monthly GnRHa in group 1 (n=18), or with a combination of GH and GnRHa in group 2 (n=17). The following growth parameters were compared between groups, and the difference (delta) before and after treatmentchronological age (CA), bone age (BA), delta(BA-CA), height (HT), target height (TH), predicted adult height (PAH), delta (TH-PAH), serum insulin-like growth factor (IGF-1) and insulin-like growth factor binding protein (IGFBP-3).

RESULTS:

Before treatment, BA, TH, PAH Standard deviation scores (SDS), delta(TH-PAH) were not different between the two groups, but CA was higher in group 2 and delta(BA-CA) were higher in group 1 (P<0.05). After 1.06+/-0.93 year of treatment, delta (BA-CA) decreased and there were significant changes in PAH and delta (TH-PAH), especially in group 2 (P<0.05 in group 1, and P<0.001 in group 2). In both groups, IGF-1 and IGFBP-3 were not different before and after treatment, but after treatment, IGF-1 level in group 2 was marginally higher than IGF-1 in group 1 (P<0.1).

CONCLUSION:

Compromised predicted adult height in girls with early puberty and advanced bone age was significantly improved with GnRH with/without GH treatment in the short-term period. The addition of GH to GnRHa results in a significant increase in PAH compared to GnRHa alone because GnRHa suppressed growth hormone-IGF-1 axis. For comparison of final adult height, further longitudinal follow-up will be needed.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Prognosis / Axis, Cervical Vertebra / Insulin-Like Growth Factor I / Growth Hormone / Carrier Proteins / Follow-Up Studies / Gonadotropin-Releasing Hormone / Puberty / Insulin-Like Growth Factor Binding Protein 3 / Hope Type of study: Controlled clinical trial / Observational study / Prognostic study Limits: Adolescent / Adult / Child / Female / Humans Language: Korean Journal: Korean Journal of Pediatrics Year: 2007 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Prognosis / Axis, Cervical Vertebra / Insulin-Like Growth Factor I / Growth Hormone / Carrier Proteins / Follow-Up Studies / Gonadotropin-Releasing Hormone / Puberty / Insulin-Like Growth Factor Binding Protein 3 / Hope Type of study: Controlled clinical trial / Observational study / Prognostic study Limits: Adolescent / Adult / Child / Female / Humans Language: Korean Journal: Korean Journal of Pediatrics Year: 2007 Type: Article